Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Scheid, Christoph (VerfasserIn) , Bertsch, Uta (VerfasserIn) , Goldschmidt, Hartmut (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: January 2014
In: Haematologica
Year: 2014, Jahrgang: 99, Heft: 1, Pages: 148-154
ISSN:1592-8721
DOI:10.3324/haematol.2013.087585
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.3324/haematol.2013.087585
Volltext
Verfasserangaben:Christof Scheid, Pieter Sonneveld, Ingo G.H. Schmidt-Wolf, Bronno van der Holt, Laila el Jarari, Uta Bertsch, Hans Salwender, Sonja Zweegman, Igor Wolfgang Blau, Edo Vellenga, Katja Weisel, Michael Pfreundschuh, Kon-Siong Jie, Kai Neben, Helgi van de Velde, Ulrich Duehrsen, M. Ron Schaafsma, Walter Lindemann, Marie José Kersten, Norma Peter, Mathias Hänel, Sandra Croockewit, Hans Martin, Shulamiet Wittebol, Gerard MJ Bos, Marinus van Marwijk-Kooy, Pierre Wijermans, Hartmut Goldschmidt, Henk M. Lokhorst

MARC

LEADER 00000caa a2200000 c 4500
001 1540250075
003 DE-627
005 20220812232421.0
007 cr uuu---uuuuu
008 160603s2014 xx |||||o 00| ||eng c
024 7 |a 10.3324/haematol.2013.087585  |2 doi 
035 |a (DE-627)1540250075 
035 |a (DE-576)470250070 
035 |a (DE-599)BSZ470250070 
035 |a (OCoLC)1340920118 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Scheid, Christoph  |e VerfasserIn  |0 (DE-588)1075475244  |0 (DE-627)833299670  |0 (DE-576)443494495  |4 aut 
245 1 0 |a Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma  |b a subgroup analysis from the HOVON-65/GMMG-HD4 trial  |c Christof Scheid, Pieter Sonneveld, Ingo G.H. Schmidt-Wolf, Bronno van der Holt, Laila el Jarari, Uta Bertsch, Hans Salwender, Sonja Zweegman, Igor Wolfgang Blau, Edo Vellenga, Katja Weisel, Michael Pfreundschuh, Kon-Siong Jie, Kai Neben, Helgi van de Velde, Ulrich Duehrsen, M. Ron Schaafsma, Walter Lindemann, Marie José Kersten, Norma Peter, Mathias Hänel, Sandra Croockewit, Hans Martin, Shulamiet Wittebol, Gerard MJ Bos, Marinus van Marwijk-Kooy, Pierre Wijermans, Hartmut Goldschmidt, Henk M. Lokhorst 
264 1 |c January 2014 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 03.06.2016 
700 1 |a Bertsch, Uta  |e VerfasserIn  |0 (DE-588)1026849861  |0 (DE-627)727494163  |0 (DE-576)372176224  |4 aut 
700 1 |a Goldschmidt, Hartmut  |d 1956-  |e VerfasserIn  |0 (DE-588)102258023X  |0 (DE-627)717003809  |0 (DE-576)365637386  |4 aut 
773 0 8 |i Enthalten in  |t Haematologica  |d Pavia : Ferrata Storti Foundation, 2014  |g 99(2014), 1, Seite 148-154  |h Online-Ressource  |w (DE-627)814204899  |w (DE-600)2805244-4  |w (DE-576)424051125  |x 1592-8721  |7 nnas  |a Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma a subgroup analysis from the HOVON-65/GMMG-HD4 trial 
773 1 8 |g volume:99  |g year:2014  |g number:1  |g pages:148-154  |g extent:7  |a Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma a subgroup analysis from the HOVON-65/GMMG-HD4 trial 
856 4 0 |u http://dx.doi.org/10.3324/haematol.2013.087585  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20160603 
993 |a Article 
994 |a 2014 
998 |g 102258023X  |a Goldschmidt, Hartmut  |m 102258023X:Goldschmidt, Hartmut  |d 910000  |d 910100  |e 910000PG102258023X  |e 910100PG102258023X  |k 0/910000/  |k 1/910000/910100/  |p 28 
998 |g 1026849861  |a Bertsch, Uta  |m 1026849861:Bertsch, Uta  |d 910000  |d 910100  |e 910000PB1026849861  |e 910100PB1026849861  |k 0/910000/  |k 1/910000/910100/  |p 6 
999 |a KXP-PPN1540250075  |e 2927006059 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"person":[{"role":"aut","given":"Christoph","display":"Scheid, Christoph","family":"Scheid"},{"role":"aut","given":"Uta","display":"Bertsch, Uta","family":"Bertsch"},{"family":"Goldschmidt","display":"Goldschmidt, Hartmut","role":"aut","given":"Hartmut"}],"id":{"doi":["10.3324/haematol.2013.087585"],"eki":["1540250075"]},"recId":"1540250075","relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"recId":"814204899","id":{"zdb":["2805244-4"],"issn":["1592-8721"],"eki":["814204899"]},"title":[{"title_sort":"Haematologica","subtitle":"journal of the European Hematology Association : journal of the Ferrata Storti Foundation","title":"Haematologica"}],"origin":[{"publisherPlace":"Pavia","publisher":"Ferrata Storti Foundation","dateIssuedKey":"2014","dateIssuedDisp":"2014-"}],"note":["Gesehen am 27.05.2022"],"pubHistory":["99.2014 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma a subgroup analysis from the HOVON-65/GMMG-HD4 trialHaematologica","language":["eng"],"titleAlt":[{"title":"journal of the European Hematology Association"}],"part":{"pages":"148-154","year":"2014","text":"99(2014), 1, Seite 148-154","issue":"1","extent":"7","volume":"99"}}],"physDesc":[{"extent":"7 S."}],"name":{"displayForm":["Christof Scheid, Pieter Sonneveld, Ingo G.H. Schmidt-Wolf, Bronno van der Holt, Laila el Jarari, Uta Bertsch, Hans Salwender, Sonja Zweegman, Igor Wolfgang Blau, Edo Vellenga, Katja Weisel, Michael Pfreundschuh, Kon-Siong Jie, Kai Neben, Helgi van de Velde, Ulrich Duehrsen, M. Ron Schaafsma, Walter Lindemann, Marie José Kersten, Norma Peter, Mathias Hänel, Sandra Croockewit, Hans Martin, Shulamiet Wittebol, Gerard MJ Bos, Marinus van Marwijk-Kooy, Pierre Wijermans, Hartmut Goldschmidt, Henk M. Lokhorst"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title":"Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma","title_sort":"Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma","subtitle":"a subgroup analysis from the HOVON-65/GMMG-HD4 trial"}],"origin":[{"dateIssuedKey":"2014","dateIssuedDisp":"January 2014"}],"note":["Gesehen am 03.06.2016"]} 
SRT |a SCHEIDCHRIBORTEZOMIB2014